Citations (90)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Patrik Nasr, Annette Hilliges, Lars Thorelius, Stergios Kechagias & Mattias Ekstedt. (2016) Contrast-enhanced ultrasonography could be a non-invasive method for differentiating none or mild from severe fibrosis in patients with biopsy proven non-alcoholic fatty liver disease. Scandinavian Journal of Gastroenterology 51:9, pages 1126-1132.
Read now
Read now
Mattias Ekstedt, Lennart E. Franzén, Marika Holmqvist, Preben Bendtsen, Ulrik L. Mathiesen, Göran Bodemar, Mattias Ekstedt, Lennart E. Franzén, Marika Holmqvist, Preben Bendtsen, Ulrik L. Mathiesen, Göran Bodemar & Stergios Kechagias. (2009) Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease. Scandinavian Journal of Gastroenterology 44:3, pages 366-374.
Read now
Read now
Einar Björnsson & Paul Angulo. (2007) Non-alcoholic fatty liver disease. Scandinavian Journal of Gastroenterology 42:9, pages 1023-1030.
Read now
Read now
Articles from other publishers (87)
Paulina Vidal-Cevallos, Nayelli Flores-García, Norberto C. Chávez-Tapia & Naga P. Chalasani. (2024) Occult liver disease: A multinational perspective. Annals of Hepatology, pages 101480.
Crossref
Crossref
Rodrigue Kamga Wouambo, Gaelle Panka Tchinda, Luc Aime Kagoue Simeni, Paule Dana Djouela Djoulako, Clarisse Irene Yateu Wouambo, Ghislaine Flore Tamko Mella, Eric Pascal Tchoumi Leuwat, Djoda Bello & Joseph Fokam. (2023) Anti-hepatitis C antibody carriage and risk of liver impairment in rural-Cameroon: adapting the control of hepatocellular carcinoma for resource-limited settings. BMC Infectious Diseases 23:1.
Crossref
Crossref
Guilherme Grossi Lopes Cançado, Aline Coelho Rocha Candolo, Mateus Jorge Nardelli, Patricia Momoyo Zitelli, Daniel Ferraz de Campos Mazo, Claudia Pinto Oliveira, Marlone Cunha-Silva, Raquel Dias Greca, Roberta Chaves Araújo, Amanda Sacha Paulino Tolentino Alustau, Cláudia Alves Couto, Gabriel Rezende de Lima Roque, Alberto Queiroz Farias, Flair José Carrilho & Mário Guimarães Pessôa. (2023) Cryptogenic chronic hepatitis: looking for an ideal diagnostic algorithm. Frontiers in Gastroenterology 2.
Crossref
Crossref
Yubing Li, Xinyu Deng, Xiaochuan Guo, Fangling Zhang, Hefei Wu, Xuhua Qin & Xiao Ma. (2023) Preclinical and clinical evidence for the treatment of non-alcoholic fatty liver disease with soybean: A systematic review and meta-analysis. Frontiers in Pharmacology 14.
Crossref
Crossref
James H. Lewis, Sophia K. Khaldoyanidi, Carolyn D. Britten, Andrew H. Wei & Marion Subklewe. (2022) Clinical Significance of Transient Asymptomatic Elevations in Aminotransferase (TAEAT) in Oncology. American Journal of Clinical Oncology 45:8, pages 352-365.
Crossref
Crossref
Steven W. Pipe, K. Rajender Reddy & Pratima Chowdary. (2022) Gene therapy: Practical aspects of implementation. Haemophilia 28:S4, pages 44-52.
Crossref
Crossref
Ali Khalifa, David N Lewin, Roula Sasso & Don C Rockey. (2021) The Utility of Liver Biopsy in the Evaluation of Liver Disease and Abnormal Liver Function Tests. American Journal of Clinical Pathology 156:2, pages 259-267.
Crossref
Crossref
Shengliang Xin, Qiao Zhan, Xiaofan Chen, Jinghang Xu & Yanyan Yu. (2020) Efficacy of serum miRNA test as a non-invasive method to diagnose nonalcoholic steatohepatitis: a systematic review and meta-analysis. BMC Gastroenterology 20:1.
Crossref
Crossref
Zhenjuan Chen, Ancheng Wu, Hongmei Jin & Fuhui Liu. (2020) β-Sitosterol attenuates liver injury in a rat model of chronic alcohol intake. Archives of Pharmacal Research 43:11, pages 1197-1206.
Crossref
Crossref
Shivaram P. Singh & Rakesh K. Barik. (2020) NonInvasive Biomarkers in Nonalcoholic Fatty Liver Disease: Are We There Yet?. Journal of Clinical and Experimental Hepatology 10:1, pages 88-98.
Crossref
Crossref
Raúl J. Andrade, Guruprasad P. Aithal, Einar S. Björnsson, Neil Kaplowitz, Gerd A. Kullak-Ublick, Dominique Larrey & Tom H. Karlsen. (2019) EASL Clinical Practice Guidelines: Drug-induced liver injury. Journal of Hepatology 70:6, pages 1222-1261.
Crossref
Crossref
Dahryn TrivediDrDr & Snehasis JanaDrDr. (2018) Assessment of Biofield Energy Treatment on Liver Health Using Hepatocellular Carcinoma Cell Line (HepG2). Journal of Gastrointestinal Disorders and Liver function 4:1, pages 17-23.
Crossref
Crossref
Mark G. Ettel & Henry D. Appelman. (2018) Approach to the Liver Biopsy in the Patient With Chronic Low-Level Aminotransferase Elevations. Archives of Pathology & Laboratory Medicine 142:10, pages 1186-1190.
Crossref
Crossref
Eduardo Vilar-Gomez & Naga Chalasani. (2018) Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers. Journal of Hepatology 68:2, pages 305-315.
Crossref
Crossref
Marietta Stadler, Esther Bollow, Maria Fritsch, Wolfgang Kerner, Ingrid Schuetz‐Fuhrmann, Dietmar Krakow, Sigrun Merger, Michaela Riedl, Peter Jehle & Reinhard W. Holl. (2017)
Prevalence of elevated liver enzymes in adults with type 1 diabetes:
A
multicentre analysis of the
G
erman/
A
ustrian
DPV
database
. Diabetes, Obesity and Metabolism 19:8, pages 1171-1178.
Crossref
Crossref
Violeta B. Popov, Christopher C. Thompson, Nitin Kumar, Maria M. Ciarleglio, Yanhong Deng & Loren Laine. (2016) Effect of Intragastric Balloons on Liver Enzymes: A Systematic Review and Meta-Analysis. Digestive Diseases and Sciences 61:9, pages 2477-2487.
Crossref
Crossref
George Kasarala & Hans L. Tillmann. (2016) Standard liver tests. Clinical Liver Disease 8:1, pages 13-18.
Crossref
Crossref
Andrew Chadwick & Michael Marks. (2016) Low yield of unselected testing in patients with acutely abnormal liver function tests. JRSM Open 7:1, pages 205427041561130.
Crossref
Crossref
Michael Strasser, Andreas Stadlmayr, Heike Haufe, Felix Stickel, Peter Ferenci, Wolfgang Patsch, Alexandra Feldman, Daniel Weghuber, Christian Datz & Elmar Aigner. (2015) Natural course of subjects with elevated liver tests and normal liver histology. Liver International 36:1, pages 119-125.
Crossref
Crossref
Mattias Ekstedt, Hannes Hagström, Patrik Nasr, Mats Fredrikson, Per Stål, Stergios Kechagias & Rolf Hultcrantz. (2015) Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up. Hepatology 61:5, pages 1547-1554.
Crossref
Crossref
Narendra S Choudhary, Neeraj Saraf, Sanjiv Saigal, Dheeraj Gautam, Lipika Lipi & Arvinder S Soin. (2015)
Estimation of normal values of serum transaminases based on liver histology in healthy
A
sian
I
ndians
. Journal of Gastroenterology and Hepatology 30:4, pages 763-766.
Crossref
Crossref
Tawfik Khoury. (2015) Altered distribution of regulatory lymphocytes by oral administration of soy-extracts exerts a hepatoprotective effect alleviating immune mediated liver injury, non-alcoholic steatohepatitis and insulin resistance. World Journal of Gastroenterology 21:24, pages 7443.
Crossref
Crossref
Arie Regev, Leonard B. Seeff, Michael Merz, Sif Ormarsdottir, Guruprasad P. Aithal, Jim Gallivan & Paul B. Watkins. (2014) Causality Assessment for Suspected DILI During Clinical Phases of Drug Development. Drug Safety 37:S1, pages 47-56.
Crossref
Crossref
Zheng Chen, Cheng-Kun Han, Ling-Ling Pan, Hui-Jie Zhang, Zhi-Min Ma, Zhu-Feng Huang, Shi Chen, Xiong-Jie Zhuang, Zhi-Bin Li, Xiao-Ying Li, Xue-Jun Li & Shu-Yu Yang. (2014) Serum Alanine Aminotransferase Independently Correlates with Intrahepatic Triglyceride Contents in Obese Subjects. Digestive Diseases and Sciences 59:10, pages 2470-2476.
Crossref
Crossref
D. Vital Durand, J.-C. Lega, T. Fassier, T. Zenone & I. Durieu. (2013) Élévation modérée, persistante et inexpliquée des transaminases. La Revue de Médecine Interne 34:8, pages 472-478.
Crossref
Crossref
Said A. Al-Busafi & Nir Hilzenrat. (2013) Mild Hypertransaminasemia in Primary Care. ISRN Hepatology 2013, pages 1-6.
Crossref
Crossref
Trivendra Tripathi, Aijaz Ahmed Khan, Mohammad Shahid, Haris M. Khan, Mashiatullah Siddiqui, Rahat Ali Khan, Abbas Ali Mahdi & Abida Malik. (2013) Biochemical and histopathological evaluation of histamine receptors (H1R, H2R, H3R and H4R)-agonist in rabbits. Experimental and Toxicologic Pathology 65:3, pages 271-275.
Crossref
Crossref
Kristina Önnerhag, Peter M. Nilsson & Stefan Lindgren. (2013) Insulin resistance with impaired fasting glucose increases the risk of NAFLD. Open Journal of Gastroenterology 03:03, pages 170-176.
Crossref
Crossref
Einar S. Björnsson. 2013. Drug-Induced Liver Disease. Drug-Induced Liver Disease
677
685
.
Trivendra Tripathi, Mohammad Shahid, Adil Raza, Haris M. Khan, Rahat Ali Khan, Abbas Ali Mahdi, Mashiatullah Siddiqui, Abida Malik & Aijaz Ahmed Khan. (2012) Dose-dependent effect of histamine on liver function markers in immunized rabbits. Experimental and Toxicologic Pathology 64:7-8, pages 875-881.
Crossref
Crossref
Arthit Wongsaensook, Wattana Sukeepaisarnjaroen, Wisut Sukeepaisarnjaroen & Churairat Kularbkaew. (2012) Significant clinical risks and the benefits of liver biopsies in Srinagarind Hospital, Khon Kaen University, Thailand: Lessons learned from the past to the present. Interventional Medicine and Applied Science 4:2, pages 92-97.
Crossref
Crossref
Charles Helsper, Gerrit van Essen, Bernard D Frijling & Niek J de Wit. (2012) Follow-up of mild alanine aminotransferase elevation identifies hidden hepatitis C in primary care. British Journal of General Practice 62:596, pages e212-e216.
Crossref
Crossref
D. Robert Dufour. 2012. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics
1637
1693
.
Stephen H. Caldwell, Curtis K. Argo & Abdullah M. S. Al‐Osaimi. 2011. Schiff's Diseases of the Liver. Schiff's Diseases of the Liver
868
907
.
David T Arnold, Louise M Bentham, Ruth P Jacob, Richard J Lilford & Alan J Girling. (2011) Should patients with abnormal liver function tests in primary care be tested for chronic viral hepatitis: cost minimisation analysis based on a comprehensively tested cohort. BMC Family Practice 12:1.
Crossref
Crossref
Albert J. Czaja. (2011) Cryptogenic Chronic Hepatitis and Its Changing Guise in Adults. Digestive Diseases and Sciences 56:12, pages 3421-3438.
Crossref
Crossref
Trivendra Tripathi, Mohammad Shahid, Haris M. Khan, Rahat Ali Khan, Mashiatullah Siddiqui & Abbas Ali Mahdi. (2011) The Influence of histamine H1-receptor on liver functions in immunized rabbits. Saudi Journal of Biological Sciences 18:4, pages 411-418.
Crossref
Crossref
WJ van Geldrop, ME Numans, HF Berg, AM van Putten, ME Scheele & M Bouma. 2011. NHG- Standaarden voor de huisarts 2011. NHG- Standaarden voor de huisarts 2011
179
203
.
Toshiaki Gunji, Nobuyuki Matsuhashi, Hajime Sato, Kimiko Iijima, Kazutoshi Fujibayashi, Mitsue Okumura, Noriko Sasabe & Akio Urabe. (2010) Risk factors for serum alanine aminotransferase elevation: A cross-sectional study of healthy adult males in Tokyo, Japan. Digestive and Liver Disease 42:12, pages 882-887.
Crossref
Crossref
Zhaohui Cai, Anastasia M. Christianson, Lars Ståhle & Marianne Keisu. (2009) Reexamining transaminase elevation in Phase I clinical trials: the importance of baseline and change from baseline. European Journal of Clinical Pharmacology 65:10, pages 1025-1035.
Crossref
Crossref
Toshiaki Gunji, Nobuyuki Matsuhashi, Hajime Sato, Kazutoshi Fujibayashi, Mitsue Okumura, Noriko Sasabe & Akio Urabe. (2009) Light and Moderate Alcohol Consumption Significantly Reduces the Prevalence of Fatty Liver in the Japanese Male Population. The American Journal of Gastroenterology 104:9, pages 2189-2195.
Crossref
Crossref
W J van Geldrop, M E Numans, H F Berg, A M van Putten, M E Scheele & M Bouma. 2009. NHG-Standaarden voor de huisarts 2009. NHG-Standaarden voor de huisarts 2009
1409
1433
.
F. Morisco, L. Pagliaro, N. Caporaso, E. Bianco, L. Sagliocca, S. Fargion, A. Smedile, M. Salvagnini & A. Mele. (2008) Consensus recommendations for managing asymptomatic persistent non-virus non-alcohol related elevation of aminotransferase levels. Digestive and Liver Disease 40:7, pages 585-598.
Crossref
Crossref
J. de la Revilla Negro, F. Pons Renedo & J.L. Calleja Panero. (2008) Protocolo diagn?stico de la elevaci?n cr?nica de transaminasas. Medicine - Programa de Formaci?n M?dica Continuada Acreditado 10:9, pages 592-596.
Crossref
Crossref
W. Ray Kim, Steven L. Flamm, Adrian M. Di Bisceglie & Henry C. Bodenheimer. (2008) Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology 47:4, pages 1363-1370.
Crossref
Crossref
Andrzej Gabriel, Adam Ziólkowski, Pawel Radlowski, Krzysztof Tomaszek & Andrzej Dziambor. (2007) Hepatocyte steatosis in HCV patients promotes fibrosis by enhancing TGF‐β liver expression. Hepatology Research 38:2, pages 141-146.
Crossref
Crossref
Yeon Seok Seo. (2008) Normal range of serum ALT level in patients with chronic hepatitis. The Korean Journal of Hepatology 14:1, pages 116.
Crossref
Crossref
Sébastien A. Blaise, Jean-Marc Alberto, Sandra Audonnet-Blaise, Jean-Louis Guéant & Jean-Luc Daval. (2007) Influence of preconditioning-like hypoxia on the liver of developing methyl-deficient rats. American Journal of Physiology-Endocrinology and Metabolism 293:6, pages E1492-E1502.
Crossref
Crossref
Keogh & Neuberger. (2007) How should abnormal results for liver tests be investigated?. Independent Nurse 2007:9.
Crossref
Crossref
Einar Björnsson & Paul Angulo. (2007) Hepatitis C and Steatosis. Archives of Medical Research 38:6, pages 621-627.
Crossref
Crossref
Mattias Ekstedt, Lennart E. Franzén, Ulrik L. Mathiesen, Marika Holmqvist, Göran Bodemar & Stergios Kechagias. (2007) Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: A histopathological follow-up study. Journal of Hepatology 47:1, pages 135-141.
Crossref
Crossref
Sherif Saadeh. (2007) Nonalcoholic Fatty Liver Disease and Obesity. Nutrition in Clinical Practice 22:1, pages 1-10.
Crossref
Crossref
Mattias Ekstedt, Lennart E. Franzén, Ulrik L. Mathiesen, Lars Thorelius, Marika Holmqvist, Göran Bodemar & Stergios Kechagias. (2006) Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 44:4, pages 865-873.
Crossref
Crossref
Zachary T. Bloomgarden. (2006) Third Annual World Congress on the Insulin Resistance Syndrome. Diabetes Care 29:9, pages 2165-2174.
Crossref
Crossref
Harjot K Gill & George Y Wu. (2006) Non-alcoholic fatty liver disease and the metabolic syndrome: Effects of weight loss and a review of popular diets. Are low carbohydrate diets the answer?. World Journal of Gastroenterology 12:3, pages 345.
Crossref
Crossref
Hyeon Chang KimKui Son ChoiYoung Hwa JangHae Won ShinDae Jung Kim. (2006) Normal Serum Aminotransferase Levels and the Metabolic Syndrome: Korean National Health and Nutrition Examination Surveys. Yonsei Medical Journal 47:4, pages 542.
Crossref
Crossref
CHALAMALASETTY SREENIVASA BABA, GEORGE ALEXANDER, BIKKASANI KALYANI, RAKESH PANDEY, SUJATA RASTOGI, AMARESH PANDEY & GOURDAS CHOUDHURI. (2006) Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis. Journal of Gastroenterology and Hepatology 21:1, pages 191-198.
Crossref
Crossref
I. Chemin, P. Merle, R. Parana & C. Trepo. (2006) Hépatites d'étiologie inconnue. EMC - Hépatologie 1:1, pages 1-8.
Crossref
Crossref
Brent A. Neuschwander-Tetri. 2006. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology
1031
1063
.
M. E. C. Thorpe. 2006. Brackenridge’s Medical Selection of Life Risks. Brackenridge’s Medical Selection of Life Risks
655
710
.
M E C Thorpe. 2006. Brackenridge’s Medical Selection of Life Risks. Brackenridge’s Medical Selection of Life Risks
655
710
.
Brent A. Neuschwander-Tetri. (2005) Nonalcoholic Steatohepatitis and the Metabolic Syndrome. The American Journal of the Medical Sciences 330:6, pages 326-335.
Crossref
Crossref
Seela Ramesh & Arun J. Sanyal. (2005) Evaluation and management of non-alcoholic steatohepatitis. Journal of Hepatology 42:1, pages S2-S12.
Crossref
Crossref
Jeffrey B. Schwimmer, Omid Khorram, Vicki Chiu & Walter B. Schwimmer. (2005) Abnormal aminotransferase activity in women with polycystic ovary syndrome. Fertility and Sterility 83:2, pages 494-497.
Crossref
Crossref
Stephen H. Caldwell, Abdullah Al-Osaimi, Charissa Chang, Christie Davis, Elizabeth E. Hespenheide, Lisa Krugner-Higby, Anita Impaglizzo Hylton, Julia C. Iezzoni, Tri H. Le, Robert K. Nakamoto, Jan Redick & Theresa Peterson. 2005. NASH and Nutritional Therapy. NASH and Nutritional Therapy
1
43
.
Wilfried Grothe & Wolfgang E. Fleig. 2005. Medizinische Therapie 2005|2006. Medizinische Therapie 2005|2006
832
836
.
Mario Antonio Torezan‐Filho, Venancio Avancini Ferreira Alves, César Almeida Neto, Helena Sabino Fernandes & Edna Strauss. (2004) Clinical significance of elevated alanine aminotransferase in blood donors: a follow‐up study. Liver International 24:6, pages 575-581.
Crossref
Crossref
Stephen H. Caldwell & Anita Impagliazzo Hylton. 2004. Fatty Liver Disease. Fatty Liver Disease
168
180
.
Victor de L??dinghen, Michel Combes, H??l??ne Trouette, Maria Winnock, Michel Amouretti, Antoine de Mascarel & Patrice Couzigou. (2004) Should a liver biopsy be done in patients with subclinical chronically elevated transaminases?. European Journal of Gastroenterology & Hepatology 16:9, pages 879-883.
Crossref
Crossref
Melissa J. Contos, Jayanta Choudhury, A.Scott Mills & Arun J. Sanyal. (2004) The histologic spectrum of nonalcoholic fatty liver disease. Clinics in Liver Disease 8:3, pages 481-500.
Crossref
Crossref
M. Herriz Bayod & I. Herrero Santos. (2004) Protocolo diagn?stico de la hipertransaminasemia en pacientes asintom?ticos. Medicine - Programa de Formaci?n M?dica Continuada Acreditado 9:9, pages 585-588.
Crossref
Crossref
I Chemin, P Merle, R Parana & C Trepo. (2004) Hépatites d'étiologie inconnue. EMC - Hépatologie 1:1, pages 1-14.
Crossref
Crossref
B Neuschwander-Tetri. (2003) Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference. Hepatology 37:5, pages 1202-1219.
Crossref
Crossref
Lei Shen. (2003) Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey. World Journal of Gastroenterology 9:5, pages 1106.
Crossref
Crossref
Joachim Mössner, Wolfgang Stremmel, Guido Gerken, Christoph Jochum, Christian P. Strassburg, Arndt Vogel, Michael P. Manns, Wilfried Grothe, Wolfgang E. Fleig, Ulrich-Frank Pape, Thomas Berg, Bertram Wiedenmann, Matthias J. Bahr, Klaus H. W. Böker, Norbert Steudel, Wolfgang E. Fleig, Matthias Wettstein, Dieter Häussinger, Jürgen Schölmerich, Frieder Berr, Ingolf Schiefke, Tilman Sauerbruch, Birgit Terjung, Volker Keim, Ullrich Graeven, Wolff Schmiegel & Michael Böhmig. 2003. Medizinische Therapie in Klinik und Praxis. Medizinische Therapie in Klinik und Praxis
863
954
.
E. Jirillo, D. Caccavo, T. Magrone, E. Piccigallo, L. Amati, A. Lembo, C. Kalis & M. Gumenscheimer. (2016) Review: The role of the liver in the response to LPS: experimental and clinical findings. Journal of Endotoxin Research 8:5, pages 319-327.
Crossref
Crossref
Richard M. Green & Steven Flamm. (2002) AGA technical review on the evaluation of liver chemistry tests. Gastroenterology 123:4, pages 1367-1384.
Crossref
Crossref
U.L. Mathiesen, L.E. Franzen, H. Åselius, M. Resjö, L. Jacobsson, U. Foberg, A. Frydén & G. Bodemar. (2002) Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Digestive and Liver Disease 34:7, pages 516-522.
Crossref
Crossref
PAUL ANGULO & KEITH D LINDOR. (2002) Non‐alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology 17:s1.
Crossref
Crossref
Yanjun Ni, Houyu Liu, Dechang Hu, Weirong Zhe & Mingsheng Li. (2001) Clinicopathological analysis of non‐alcoholic steatohepatitis. Chinese Journal of Digestive Diseases 2:4, pages 184-187.
Crossref
Crossref
T. M. Shehab, S. S. Sonnad & A. S. F. Lok. (2001) Management of hepatitis C patients by primary care physicians in the USA: results of a national survey. Journal of Viral Hepatitis 8:5, pages 377-383.
Crossref
Crossref
Leonardo Bianchi. (2001) Liver biopsy in elevated liver functions tests? An old question revisited. Journal of Hepatology 35:2, pages 290-294.
Crossref
Crossref
Maeve M. Skelly, Peter D. James & Stephen D. Ryder. (2001) Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. Journal of Hepatology 35:2, pages 195-199.
Crossref
Crossref
D Robert Dufour, John A Lott, Frederick S Nolte, David R Gretch, Raymond S Koff & Leonard B Seeff. (2000) Diagnosis and Monitoring of Hepatic Injury. II. Recommendations for Use of Laboratory Tests in Screening, Diagnosis, and Monitoring. Clinical Chemistry 46:12, pages 2050-2068.
Crossref
Crossref
J. Paul Miller. (2000) Serum triglycerides, the liver and the pancreas. Current Opinion in Lipidology 11:4, pages 377-382.
Crossref
Crossref
Nurten Kocak, Aysel Yuce, Figen Gurakan & Hasan Ozen. (2000) Obesity: a cause of steatohepatitis in children. The American Journal of Gastroenterology 95:4, pages 1099-1100.
Crossref
Crossref
Amadeo Marcos. (2000) Right lobe living donor liver transplantation: A review. Liver Transplantation 6:1, pages 3-20.
Crossref
Crossref